Search

Your search keyword '"Hyrcza, Martin"' showing total 226 results

Search Constraints

Start Over You searched for: Author "Hyrcza, Martin" Remove constraint Author: "Hyrcza, Martin"
226 results on '"Hyrcza, Martin"'

Search Results

1. The genomic and evolutionary landscapes of anaplastic thyroid carcinoma

2. VSV∆M51 drives CD8+ T cell-mediated tumour regression through infection of both cancer and non-cancer cells

7. Canadian Multicentric Pan-TRK (CANTRK) Immunohistochemistry Harmonization Study

8. A Multicenter Study Validates the WHO 2022 Classification for Conjunctival Melanocytic Intraepithelial Lesions With Clinical and Prognostic Relevance

11. Salivary Gland Secretory Carcinoma: Clinicopathologic and Genetic Characteristics of 215 Cases and Proposal for a Grading System

15. Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma

16. Multidisciplinary Canadian consensus on the multimodal management of high-risk and radioactive iodine-refractory thyroid carcinoma.

17. VSV∆M51 drives CD8+ T cell-mediated tumour regression through infection of both cancer and non-cancer cells.

19. Nasal and sinonasal tumors formed by atypical adenomatous lesions arising in respiratory epithelial adenomatoid hamartoma/seromucinous hamartoma.

24. Branchioma: immunohistochemical and molecular genetic study of 23 cases highlighting frequent loss of retinoblastoma 1 immunoexpression

25. Canadian Multicentric Pan-TRK (CANTRK) Immunohistochemistry Harmonization Study

26. An Update on Endocrine Mucin-producing Sweat Gland Carcinoma: Clinicopathologic Study of 63 Cases and Comparative Analysis

27. Histologic Classification and Molecular Signature of Polymorphous Adenocarcinoma (PAC) and Cribriform Adenocarcinoma of Salivary Gland (CASG): An International Interobserver Study

28. A Multicenter Study Validates the WHO 2022 Classification for Conjunctival Melanocytic Intraepithelial Lesions With Clinical and Prognostic Relevance

29. Management of Uveal Melanoma: Updated Cancer Care Alberta Clinical Practice Guideline.

30. The genomic and evolutionary landscapes of anaplastic thyroid carcinoma

35. The Prospective Implementation of the 2015 ATA Guidelines and Modified ATA Recurrence Risk Stratification System for Treatment of Differentiated Thyroid Cancer in a Canadian Tertiary Care Referral Setting

37. Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response

38. Interim outcome analysis of prospective ATA recurrence risk (RR) stratification for postoperative treatment and follow up of differentiated thyroid cancer (DTC)

39. Molecular Profiling of Mammary Analog Secretory Carcinoma Revealed a Subset of Tumors Harboring a Novel ETV6-RET Translocation: Report of 10 Cases

43. Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid Carcinoma

47. A Systematic Population-Based Approach to Identify Patients With NTRK Gene Fusion-Positive and RET Gene Fusion/Mutation-Positive Thyroid Cancers Who Could Benefit from Treatment With TRK or RET Inhibitors

49. Mucoacinar Carcinoma

Catalog

Books, media, physical & digital resources